IRIS Accounts Production v24.3.0.553 13631582 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh136315822023-09-30136315822024-09-30136315822023-10-012024-09-30136315822022-09-30136315822022-10-012023-09-30136315822023-09-3013631582ns15:EnglandWales2023-10-012024-09-3013631582ns14:PoundSterling2023-10-012024-09-3013631582ns10:Director12023-10-012024-09-3013631582ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3013631582ns10:SmallEntities2023-10-012024-09-3013631582ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3013631582ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3013631582ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3013631582ns10:FullAccounts2023-10-012024-09-3013631582ns10:Director22023-10-012024-09-3013631582ns10:RegisteredOffice2023-10-012024-09-3013631582ns5:CurrentFinancialInstruments2024-09-3013631582ns5:CurrentFinancialInstruments2023-09-3013631582ns5:ShareCapital2024-09-3013631582ns5:ShareCapital2023-09-3013631582ns5:RetainedEarningsAccumulatedLosses2024-09-3013631582ns5:RetainedEarningsAccumulatedLosses2023-09-3013631582ns5:PlantMachinery2023-10-012024-09-3013631582ns5:PlantMachinery2023-09-3013631582ns5:PlantMachinery2024-09-3013631582ns5:PlantMachinery2023-09-3013631582ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3013631582ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-30136315821ns10:Director12023-09-30136315821ns10:Director12022-09-30136315821ns10:Director12023-10-012024-09-30136315821ns10:Director12022-10-012023-09-30136315821ns10:Director12024-09-30136315821ns10:Director12023-09-3013631582ns10:Director222023-09-3013631582ns10:Director222022-09-3013631582ns10:Director222023-10-012024-09-3013631582ns10:Director222022-10-012023-09-3013631582ns10:Director222024-09-3013631582ns10:Director222023-09-30
REGISTERED NUMBER: 13631582 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2024

for

S M Medics Ltd

S M Medics Ltd (Registered number: 13631582)






Contents of the Financial Statements
for the Year Ended 30 September 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


S M Medics Ltd

Company Information
for the Year Ended 30 September 2024







DIRECTORS: Mrs V M Ganjam
Dr S R Ganjam





REGISTERED OFFICE: 8 Coalport Walk
St Helens
Merseyside
WA9 5GD





REGISTERED NUMBER: 13631582 (England and Wales)





ACCOUNTANTS: Kinsella Clarke Limited
61 Stanley Road
Bootle
Merseyside
L20 7BZ

S M Medics Ltd (Registered number: 13631582)

Statement of Financial Position
30 September 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,793 2,390

CURRENT ASSETS
Debtors 5 545 2
Cash at bank 60,034 69,994
60,579 69,996
CREDITORS
Amounts falling due within one year 6 11,189 16,718
NET CURRENT ASSETS 49,390 53,278
TOTAL ASSETS LESS CURRENT
LIABILITIES

51,183

55,668

PROVISIONS FOR LIABILITIES 341 454
NET ASSETS 50,842 55,214

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 50,840 55,212
SHAREHOLDERS' FUNDS 50,842 55,214

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

S M Medics Ltd (Registered number: 13631582)

Statement of Financial Position - continued
30 September 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 November 2024 and were signed on its behalf by:





Dr S R Ganjam - Director


S M Medics Ltd (Registered number: 13631582)

Notes to the Financial Statements
for the Year Ended 30 September 2024

1. STATUTORY INFORMATION

S M Medics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

S M Medics Ltd (Registered number: 13631582)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023
and 30 September 2024 3,580
DEPRECIATION
At 1 October 2023 1,190
Charge for year 597
At 30 September 2024 1,787
NET BOOK VALUE
At 30 September 2024 1,793
At 30 September 2023 2,390

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors 543 -
Other debtors 2 2
545 2

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Taxation and social security 9,092 15,689
Other creditors 2,097 1,029
11,189 16,718

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 September 2024 and 30 September 2023:

30.9.24 30.9.23
£    £   
Dr S R Ganjam
Balance outstanding at start of year (396 ) (108 )
Amounts repaid (429 ) (288 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (825 ) (396 )

S M Medics Ltd (Registered number: 13631582)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

Mrs V M Ganjam
Balance outstanding at start of year (396 ) (108 )
Amounts repaid (429 ) (288 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (825 ) (396 )